Evid Invest
Who owns RDHLWhat RDHL owns — n/a

Who owns RedHill Biopharma Ltd.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.

Institutional ownership of RDHL from SEC Form 13F filings across 13 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-06-30 reporting period, 13 institutions disclosed 193,732 shares of RedHill Biopharma Ltd. worth $163,405 — about 0% of shares outstanding; the largest disclosed holder is GAGNON SECURITIES LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

13

13F holders

$163,405

value, 2026 filers

0%

of shares outstanding (193,732 sh)

3

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of RDHL's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1GAGNON SECURITIES LLC88,405$74,7020.0%0%0.0%
2CITADEL ADVISORS LLC65,321$55,1960.0%0%+216.0%
3RHUMBLINE ADVISERS13,755$11,6200.0%0%+168.9%
4Lido Advisors, LLCNEW11,009$9,3030.0%0%new
5GAMMA Investing LLC6,957$5,8790.0%0%+4.1%
6CITIGROUP INCNEW4,378$3,6990.0%0%new
7Federation des caisses Desjardins du Quebec3,388$2,8630.0%0%0.0%
8ROYAL BANK OF CANADA351$00.0%0%+35000.0%
9UBS Group AG100$850.0%0%-87.9%
10MERCER GLOBAL ADVISORS INC /ADVNEW50$420.0%0%new
11SBI Securities Co., Ltd.15$130.0%0%+275.0%
12Vermillion Wealth Management, Inc.2$20.0%0%0.0%
13MORGAN STANLEY1$10.0%0%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.